Beyond Osteopathic Therapy: Functional Performance Following the Addition of Ujjayi Pranayama in College Students With Upper Cross Syndrome

What this study involves

The registry says this study is recruiting. Individual locations may have different availability.

Study type

Interventional

Phase

Not applicable

Age range

20 years - 29 years

Sex eligible

Male

Healthy volunteers

Not accepted

Participants

40 Estimated

These are starting points, not an eligibility decision. The research team must review the full requirements.

About the research

This study aims to explore the relationship between spinal alignment and functional performance in individuals with upper cross syndrome following a combined breathing and manual therapy program. It is designed as a secondary analysis of data obtained from a previously conducted randomized controlled trial, with the addition of objective spinal measurements using the Spinal Mouse device. Functional performance will be assessed using standardized tests such as the 6-minute walk test and the timed up and go test. Statistical analysis will include correlation and regression models to determine whether spinal alignment parameters can predict functional outcomes. The findings are expected to provide insight into the biomechanical role of posture in functional recovery among individuals with upper cross syndrome.

Who may be able to participate?

The list below is the sponsor’s full registry wording. It can include conditions, prior treatment, test results and other requirements. A match in search does not mean you qualify.

Inclusion Criteria:

• Full time college students of age 20-29 years.

• Subjects who have upper cross syndrome according to REEDCO posture assessment.
• Subjects who not receiving medical treatment for respiratory diseases .
• Subjects who have clean family medical history.

Exclusion Criteria:

• Subjects who engaged in additional exercise in two weeks, which was likely to affect the results of the research .
• Individuals with a history of spine, shoulder fractures, surgery, or other disease.
• Individuals with severe cardia-cerebrovascular disease.
• Individuals who will have difficulty to follow-up testing).
• Neurologic and psychiatric disorders (who can not understand the research project ).
• Individuals with congenital deformities

Treatment, groups and participation

The registry may describe treatments and study duration without a complete visit calendar. Ask the study team for the exact schedule, procedures, risks, costs and alternatives. Keep your usual care plan unless your treating clinician tells you otherwise.

Assignment

Random assignment

Masking

Double masked

What researchers are measuring

Outcome measures describe what is being studied. They are not proof that a treatment works.

Primary measures

Secondary measures

Research locations (1)

The overall study status and a local site’s status can differ. Confirm that location’s availability before traveling.

1 locations

Study team and timeline

Lead sponsor

Al-Zaytoonah University of Jordan

Study start

Aug 25, 2026 Actual

Primary completion

Oct 25, 2026 Actual

Study completion

Nov 15, 2026 Estimated

First posted

Aug 26, 2026 Actual

Last updated

Nov 10, 2026 Actual

Official study contacts

No central contact is listed. Check the locations and the official record.